| Literature DB >> 35979844 |
Yuyan Wang1, Dali Wang1, Jiachen Lin1, Zidi Lyu1, Peiru Chen1, Tingyu Sun1, Chenyang Xue1, Mehrnaz Mojtabavi2, Armin Vedadghavami2, Zheyu Zhang1, Ruimeng Wang1, Lei Zhang1, Christopher Park1, Gyu Seong Heo3, Yongjian Liu3, Sijia S Dong1, Ke Zhang4.
Abstract
Aptamers face challenges for use outside the ideal conditions in which they are developed. These difficulties are most palpable in vivo due to nuclease activities, rapid clearance, and off-target binding. Herein, we demonstrate that a polyphosphodiester-backboned molecular brush can suppress enzymatic digestion, reduce non-specific cell uptake, enable long blood circulation, and rescue the bioactivity of a conjugated aptamer in vivo. The backbone along with the aptamer is assembled via solid-phase synthesis, followed by installation of poly(ethylene glycol) (PEG) side chains using a two-step process with near-quantitative efficiency. The synthesis allows for precise control over polymer size and architecture. Consisting entirely of building blocks that are generally recognized as safe for therapeutics, this novel molecular brush is expected to provide a highly translatable route for aptamer-based therapeutics.Entities:
Keywords: Anticoagulant; Aptamer; Bottlebrush Polymer; Oligonucleotides; PEGylation
Mesh:
Substances:
Year: 2022 PMID: 35979844 PMCID: PMC9529849 DOI: 10.1002/anie.202204576
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 16.823